InnoCare Pharma Limited (HKG:9969)
Hong Kong
· Delayed Price · Currency is HKD 12.05
+0.27 (2.29%)
Mar 10, 2026, 10:03 AM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 23.64 billion as of March 9, 2026. Its market cap has increased by 83.24% in one year.
Market Cap
23.64B
Enterprise Value
17.80B
Revenue
1.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
12.05
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 23.64B, an increase of 92.54%. That is a compound annual growth rate of 11.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PegBio | 23.50B |
| Genscript Biotech | 24.99B |
| Duality Biotherapeutics | 28.45B |
| Shanghai Junshi Biosciences | 32.13B |
| Zai Lab | 17.13B |
| Ascentage Pharma Group International | 16.66B |
| Biocytogen Pharmaceuticals (Beijing) | 35.60B |
| Keymed Biosciences | 15.44B |